Lenacapavir, an antiretroviral drug typically used to treat HIV infections, can also effectively prevent them, a phase 3 ...

Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons,” published in the November 2024 issue of Infectious ...

In a population of cisgender men, transgender women, transgender men, and gender-nonbinary persons, the incidence of H ...

A new HIV prevention method, Lenacapavir, administered as a twice-yearly injection, has demonstrated superior results ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

Lenacapavir will be available at low cost in 120 poor countries. But nearly all of Latin America was excluded from a deal ...

Sunlenca's biannual shot could revolutionize HIV prevention, but access remains a key barrier, particularly in Latin America.

World AIDS Day is observed on December 1 annually. The theme this year is ‘Take the Rights Path: My Health, My Right’. It is ...

Tengrinews.kz - A revolutionary HIV drug has been created: clinical trials have shown that its twice-yearly injections are 96 ...

Less than three hundred women had accessed the vaginal ring through that initiative by the end of August 2024. While Atwine says lenacapavir will be a game-changer in terms of reducing the burden of ...